UPDATE 1-FDA approves Pfizer's drug for rare blood cancer
August 17, 2017 at 14:26 PM EDT
Aug 17 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's rare blood cancer drug, Besponsa, with a boxed warning.
